Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · VIEMED HEALTHCARE, INC. (VMD)

VieMed Healthcare Deck Shows 2Q26 Revenue Up 24%, Reaffirms 2026 Guidance, New Buyback

Positive Impact 3 of 5 earnings Written later

VieMed Healthcare furnished an August 2026 investor presentation under Regulation FD that reports second-quarter 2026 net revenue of $78.1 million, up 24% from a year earlier, and Adjusted EBITDA of $13.7 million. The deck restates full-year 2026 guidance and says the board authorized a new share repurchase program of up to 5% of shares outstanding.

Key points

  • 2Q 2026 net revenue was $78.1 million, up 24% year over year; Adjusted EBITDA was $13.7 million.
  • 2026 guidance: net revenue of $314 million to $320 million and Adjusted EBITDA of $64 million to $68 million.
  • New share repurchase program authorized for up to 5% of shares outstanding; 680,802 shares were bought in 1H 2026 for $6.5 million.
  • Net debt was effectively zero as of June 30, 2026, with $46 million of unfunded credit facility commitments.

The filing

CompanyVIEMED HEALTHCARE, INC. (VMD)
Form8-K, current report
Filed with the SECAug 20, 2026, 5:03 PM ET
Accession number0001729149-26-000048

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.